Feedback / Questions
tarextumab (OMP-59R5) - MorphoSys, Mereo Biopharma, GSK
Morphosys: J.P. Morgan Healthcare Conference
(Morphosys)
-
Jan 15, 2015 -
Anticipated data from P2 trial in pancreatic cancer in 2016
Anticipated P2 data
•
Oncology • Pancreatic Cancer
http://jpmorgan.metameetings.com/confbook/healthcare15/ciwc.php?webfeed=1&p=17039
Jan 15, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.